Ian Wendt

Chief Commercial Officer

2020

Full P&L responsibility for US assets in Human Health and Animal Health divisions. Provided board-level executive leadership regarding short and long-term strategic planning and execution. Key Achievements • Successfully turned around an inline retail channel asset to specialty pharmacy distribution and implemented a suite of patient support programs that improved medication access. GTN increased from ~30% to ~75% over a two-year transition period. Most recent year-over-year net sales increased by 112% for a 10-year-old drug with flat spending. Gross profit increased by 8x from 2019 to 2022. • Achieved operating profitability in 2021 for the commercial team for the first time in the company’s history. • Led launch planning and market-shaping activities for a chloride ion channel modulator in the Oncology supportive care market. • Launched a first-in-class chloride ion channel modulator in the veterinary Oncology market. • Supported a variety of BD efforts that resulted in two ex-US licensing deals for commercial assets.

Vice President Commercial Strategy

2019 - 2020

Led commercial efforts across marketing, sales, and operations. Key Achievements • Transitioned Jaguar Health and Napo Pharmaceuticals from a development stage organization into a commercial business. Implemented a variety of systems and technologies to enable the company to better manage its business. • Launched new branded and unbranded campaigns to support US commercial asset. • Built a new commercial operations team to support commercial efforts across medication access, patient support, trade/distribution, and pricing. • Increased net revenue and gross revenue from 2019-2020 by 64% and 148%, respectively.

Advisory Board Member

2020

Executive Director - HIV Field Operations

2018 - 2019

Led a national team of 30 field employees that drove market development outcomes in the HIV treatment and prevention markets. Key Achievements • Developed and executed a Market Development strategy for Gilead in support of a $13B franchise • Evolved team to Strategic Account Management focus that included development and adoption of a competency-based performance model as well as ongoing skills training which supported key account strategy • Led national field force size and structure analysis • Field team’s public health engagements not only supported commercial outcomes but were published and presented at major HIV conferences

Senior Director - HIV Marketing and Operations

2017 - 2018

Led the Gilead HIV Community Commercial Strategy, Marketing and Field Operations for a national team of 30. Key Achievements • Responsible for the development of the Gilead HIV Commercial Community strategy as part of the HIV Business Unit • Launched the most successful antiretroviral in HIV market history (Biktarvy) • Managed $2M to support tactical development in support of the commercial strategy • Established key implementation strategy through market research, concept development, tactical development, and execution

Director - HCV Market Development Lead

2017 - 2017

Led the Hepatitis C Market Development team across HCP, NPP, Conferences, and Community. Key Achievements • Managed four marketing direct reports plus agency contractors and 21 PSR sales contractors • Responsible for a $36M promotional budget • Launched Vosevi for HCV treatment failures • Developed HCV Market Development Business Unit POA • Led Virtual Engagement optimization program

Director - HCV Marketing

2016 - 2017

Managed the field POA for HCP non-specialists in the Hepatitis C market. Key Achievements • Led key initiatives to operationalize a new market development field team • Launched Epclusa as a cure for Hepatitis C • Transitioned the team to an Account Management model focused on Policy and Protocol in major accounts to drive routinized screening, diagnosis, and referrals

Regional Director - HIV Field Operations

2011 - 2016

Managed field team which delivered patient and allied health care professional HIV education for Western United States. Key Achievements • Regional Director Leadership awards 2012 & 2016 • President’s Club Award 2012 • Led transition of key community initiatives through national health care reform

Senior Specialty Regional Sales Director

2001 - 2011

Led multiple sales regions across the Western and Central US for HIV franchise. Primary product responsibilities for Viramune and Aptivus. Key Achievements • 2011 ranked #1 region nationally • Consistently ranked in the top 20% of regional sales results • #1 region for Viramune market share from 2007-2011

Senior Area Sales Director

1997 - 2001

Sales Leader for HIV and Palliative Care franchises across Western and Central US.

Director Commercial Operations

1994 - 1997

Led teams across Sales Operations, Sales Analytics, Incentive Compensation and Training functions. Key Achievements • Designed and developed the HIV training programs for the Viramune product launch • Responsible for commercial operations across three different sales forces • Completed national realignment and build out of new field based sales teams • Managed outbound call center with national accounts / key accounts focus

Regional Director of Pharmaceutical Affairs

1994 - 1994

Managed portfolio of HIV and Pain Management products in Northern California across professional and national accounts customers.

Cardiovascular Sales Specialist

1993 - 1994

Sales Representative

1991 - 1993

Owner and Partner

1990 - 1991

Owner and partner in a marketing services consultancy serving clients across Eastern Canada during my MBA program.